- Investing Ideas
- Indian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Indian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
1 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
Strides Pharma Science
Market Cap: ₹99.6b
Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.
STAR
₹1,080.80
7D
-1.2%
1Y
23.8%
Piramal Pharma
Market Cap: ₹223.1b
Operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally.
New
PPLPHARMA
₹168.11
7D
-0.3%
1Y
-16.6%